Lexington, MA, United States of America

R Yongxin Zhao

This inventor holds 6 USPTO granted patents. Top assignee: Hangzhou Dac Biotech Co., Ltd.. Active years: 2018-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: R Yongxin Zhao. Retrieved from https://idiyas.com/inventor/r-yongxin-zhao

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 2.3

ph-index = 3

Forward Citations = 64(Granted Patents)


Location History:

  • Zhengzhou, CN (2019)
  • Lexington, MA (US) (2018 - 2024)

Company Filing History:


Years Active: 2018-2024

Loading Chart...
6 patents (USPTO):Explore Patents

Title: R Yongxin Zhao: Innovator in Targeted Therapeutics

Introduction

R Yongxin Zhao is a prominent inventor based in Lexington, MA (US), known for his significant contributions to the field of biotechnology. He holds a total of six patents, focusing on innovative solutions for targeted treatment of various diseases.

Latest Patents

Among his latest patents are conjugates of cell binding molecules with cytotoxic agents. These conjugates involve a potent cytotoxic agent linked to a cell-binding molecule, which can be utilized for the targeted treatment of cancer, autoimmune diseases, and infectious diseases. The detailed structure of these conjugates is represented by specific formulas, allowing for precise applications in medical therapies.

Career Highlights

R Yongxin Zhao is currently associated with Hangzhou Dac Biotech Co., Ltd., where he continues to advance his research and development efforts. His work is pivotal in creating innovative therapeutic solutions that address critical health challenges.

Collaborations

He collaborates with notable colleagues, including Yue Zhang and Yourang Ma, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

R Yongxin Zhao's work exemplifies the intersection of innovation and healthcare, making significant strides in targeted therapies. His contributions are vital for the advancement of medical treatments and improving patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…